This is a UK news story, published by Sky News.
For more UK news, you can click here:
more UK newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Sky News, you can click here:
more news from Sky NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Ocular Melanoma UK. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest metastatic uveal melanoma news, eye cancer news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
uveal melanomaSky News
•Health
Health
70% Informative
Patients diagnosed with uveal melanoma can now be offered a drug called tebentafusp.
The drug works by attaching to the proteins on the surface of cancer cells.
It helps the immune system recognise and kill cancer cells, slowing the growth of the disease.
The cancer is thought to affect between 500 and 600 people in the UK each year .
VR Score
61
Informative language
56
Neutral language
39
Article tone
informal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links
